Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.
Garg R, Liu Q, Van Kessel J, Asavajaru A, Uhlemann EM, Joessel M, Hamonic G, Khatooni Z, Kroeker A, Lew J, Scruten E, Pennington P, Deck W, Prysliak T, Nickol M, Apel F, Courant T, Kelvin AA, Van Kessel A, Collin N, Gerdts V, Köster W, Falzarano D, Racine T, Banerjee A.
Garg R, et al. Among authors: uhlemann em.
Vaccine. 2024 May 19:S0264-410X(24)00586-3. doi: 10.1016/j.vaccine.2024.05.028. Online ahead of print.
Vaccine. 2024.
PMID: 38769033